US Patent Issued to Shanghai Argo Biopharmaceutical on Jan. 27 for "Composition and method for inhibiting angiotensinogen (AGT) protein expression" (Chinese, American Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,726, issued on Jan. 27, was assigned to Shanghai Argo Biopharmaceutical Co. Ltd. (Shanghai).

"Composition and method for inhibiting angiotensinogen (AGT) protein expression" was invented by Dongxu Shu (Ningbo, China) and Pengcheng Patrick Shao (Warrington Township, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a composition and method for inhibiting angiotensinogen (AGT) protein expression. Specifically, provided are a composition and method capable of being used for reducing AGT gene expression and treating AGT-related diseases and disorders. Provided are an AGT dsRNA reagent capable of being used for reducing AGT expression in a ...